Showing results (11-20 of 355) with videos related to
Sort By:
Pageof 36
Journal of Immunological Methods|May 24, 2006
Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cellsDavid T Montag, Michael T LotzeJournal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2004
Addicted to death: invasive cancer and the immune response to unscheduled cell deathHerbert J Zeh, Michael T LotzeCancer Gene Therapy|July 24, 2002
Viruses as gene delivery vectors: application to gene function, target validation, and assay developmentMichael T Lotze, Thomas A KostMethods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Targeting damage-associated molecular pattern molecules (DAMPs) and DAMP receptors in melanomaBrian A Boone, Michael T LotzeDiscovery Medicine|August 14, 2010
Dying dangerously: Necrotic cell death and chronic inflammation promote tumor growthMichael T Lotze, Richard A DemarcoCurrent Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
Dealing with death: HMGB1 as a novel target for cancer therapyMichael T Lotze, Richard A DeMarcoNature Reviews. Immunology|April 2, 2005
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenalMichael T Lotze, Kevin J TraceyJournal for Immunotherapy of Cancer|June 29, 2026
DEA hypothesis: disinhibition, enhancing recognition, and alerting the host are the three pillars of effective cancer immunotherapyXiao-Song Wang, Michael T LotzeClinical Immunology (Orlando, Fla.)|September 9, 2006
Rapid flow cytometric measurement of cytokine-induced phosphorylation pathways [CIPP] in human peripheral blood leukocytesDavid T Montag, Michael T LotzeCancer Immunology, Immunotherapy : CII|January 22, 2004
Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cellsMichael T Lotze, Robert C ReesPageof 36